Page last updated: 2024-10-22

amiodarone and Granulocytic Leukemia

amiodarone has been researched along with Granulocytic Leukemia in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, S1
Toyoda, Y1
Fukami, T1
Nakajima, M1
Yokoi, T1
Boesch, D1
Muller, K1
Pourtier-Manzanedo, A1
Loor, F1

Other Studies

2 other studies available for amiodarone and Granulocytic Leukemia

ArticleYear
Stimulation of human monocytic THP-1 cells by metabolic activation of hepatotoxic drugs.
    Drug metabolism and pharmacokinetics, 2012, Volume: 27, Issue:6

    Topics: Albendazole; Amiodarone; B7-2 Antigen; Biotransformation; Cell Line, Tumor; Chemical and Drug Induce

2012
Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative.
    Experimental cell research, 1991, Volume: 196, Issue:1

    Topics: Amiodarone; Animals; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance;

1991